Candel Therapeutics, Inc. (CADL) Tops Q1 EPS by 50c

Candel Therapeutics, Inc. (NASDAQ: CADL) reported Q1 EPS of $0.13, $0.50 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Candel Therapeutics, Inc. (CADL) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• El Pollo Loco opens first Idaho location, now in 10 states
• Hologic recalls BioZorb markers after reported injuries - FDA